Learn how Dr Michael Thurn (CEO) maximised investor attention and demand by keeping investors and shareholders engaged at scale throughout their latest capital raise.
Industry: Biotechnology
Headquarters: Melbourne
Market cap: ~$95m
Here's how PharmAust and Dr Michael Thurn leverage InvestorHub as part of their direct-to-investor marketing strategy during their latest capital raise to engage all their shareholders at scale and raise $17.8m in total.
PharmAust introduced the capital raise to the market via their hub, where shareholders were able to ask questions directly of management.
They shared the details of their capital raise at scale with an email campaign to direct shareholders to a dedicated SPP landing page.
A dedicated SPP landing page gave shareholders access to all the required details to participate and learn more about the capital raise.
Dr Michael Thurn included a video summary that contextualised why PharmAust was raising capital to add context for shareholders as part of the SPP.
PharmAust made sure to address the market and thank shareholders for participating while taking the opportunity to reinforce the use of funds.
Book a discovery call with InvestorHub today. No hard sell, no jargon, just a friendly chat about you, your company, and whether InvestorHub can help you reach your goals.